2026-05-20T23:32:28Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/200242025-05-07T12:30:18Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967
Repisalud
author
Gonzalez-Martin, A.
author
Bover Barceló, Isabel
author
Del Campo, Jose Maria
author
Redondo, A
author
Vidal Bonet, Laura
2024-07-03T11:09:40Z
2024-07-03T11:09:40Z
2014-12
Gonzalez-Martin A, Bover I, Del Campo JM, Redondo A, Vidal Bonet L. SEOM guideline in ovarian cancer 2014. Clin Transl Oncol. 2014 Dec;16(12):1067-71. Epub 2014 Oct 29.
10.1007/s12094-014-1229-z
1699-3055
1699-048X
Clinical & Translational Oncology
http://hdl.handle.net/20.500.13003/11051
25351169
L600985484
2-s2.0-84919327586
http://hdl.handle.net/20.500.12105/20024
345397300007
Ovarian cancer is the leading cause of death due to gynecological cancer and the 5th cause of death for cancer in women in Europe. Optimal management of patients with ovarian cancer needs the participation of a well-trained multidisciplinary team. In the last few years, we have observed a significant improvement in the knowledge of the molecular biology of the different histotypes of ovarian cancer that will probably change our standard of care in the forthcoming years. In this Guideline, we summarize the most current evidence for the medical management of ovarian cancer.
eng
Ovarian cancer
Treatment guidelines
First line
Recurrent disease
SEOM guideline in ovarian cancer 2014
research article